Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin

被引:9
作者
Kumar, Ramya K. [1 ]
Darios, Emma S. [1 ]
Burnett, Robert [1 ]
Thompson, Janice M. [1 ]
Watts, Stephanie W. [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, 1355 Bogue St,Rm B445, E Lansing, MI 48824 USA
基金
美国国家卫生研究院;
关键词
Serotonin (5-HT); Norepinephrine (NE); Perivascular adipose tissue (PVAT); Fenfluramine; PROINFLAMMATORY PHENOTYPE; ADIPOSE-TISSUE; RECEPTORS; ADIPOCYTES; SYSTEM;
D O I
10.1016/j.phrs.2018.08.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Perivascular adipose tissue (PVAT) modulates vascular tone and altered PVAT function is observed in vascular diseases such as hypertension and atherosclerosis. We discovered that the PVAT surrounding rat thoracic aorta (RA) and the superior mesenteric artery (SMA) contain significant amounts of 5-hydroxytryptamine (5-HT). We hypothesized that the 5-HT contained within the PVAT is functional and vasoactive. Isolated tissue baths were used for isometric contractility studies and high performance liquid chromatography was used to quantitatively measure amines in the PVAT and release studies. The 5-HT releaser fenfluramine (10 nM-100 mu M) was tested for its ability to contract arteries with and without PVAT. Contraction was reported as a percentage of the initial contraction to 10 mu M phenylephrine. The RA with PVAT contracted to fenfluramine to a greater maximum (98 +/- 10%) than RA without PVAT (24 +/- 4%), while no difference in contraction of SMA to maximum fenfluramine with (78 +/- 2%) and without (75 +/- 6%) PVAT was observed. Contradicting our hypothesis, the maximum contraction of RA with PVAT to fenfluramine was diminished by the alpha-1 adrenoreceptor antagonist prazosin (100 nM; vehicle: 71 +/- 4%, prazosin: 24 +/- 2%) and the norepinephrine transporter (NET) inhibitor nisoxetine (1 mu M; vehicle: 71 +/- 4%, nisoxetine: 25 +/- 4%) but not the 5-HT2A/2C receptor antagonist ketanserin (10 nM) or serotonin specific reuptake inhibitor fluoxetine (10 mu M). To test if fenfluramine caused release of 5-HT or NE from PVAT, PVAT from RA was incubated with vehicle or fenfluramine (10 mu M-10 mM), and amines released into the incubating buffer were quantified. A pronounced concentration-dependent NE-release (more than 5-HT) was observed. Collectively, this research illustrates the pharmacology of fenfluramine to primarily stimulate NE release (better than 5-HT) in a NET-dependent manner, leading to vasoconstriction. This adds additional support to PVAT as being an important reservoir of amines.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 35 条
  • [1] Immunomodulatory Effects Mediated by Serotonin
    Arreola, Rodrigo
    Becerril-Villanueva, Enrique
    Cruz-Fuentes, Carlos
    Velasco-Velazquez, Marco Antonio
    Garces-Alvarez, Maria Eugenia
    Hurtado-Alvarado, Gabriela
    Quintero-Fabian, Saray
    Pavon, Lenin
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [2] Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue
    Ayala-Lopez, Nadia
    Jackson, William F.
    Burnett, Robert
    Wilson, James N.
    Thompson, Janice M.
    Watts, Stephanie W.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (11): : H1904 - H1914
  • [3] Perivascular adipose tissue contains functional catecholamines
    Ayala-Lopez, Nadia
    Martini, Marisa
    Jackson, William F.
    Darios, Emma
    Burnett, Robert
    Seitz, Bridget
    Fink, Gregory D.
    Watts, Stephanie W.
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2014, 2 (03):
  • [4] Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
    Ball, Helen J.
    Yuasa, Hajime J.
    Austin, Christopher J. D.
    Weiser, Silvia
    Hunt, Nicholas H.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (03) : 467 - 471
  • [5] THE PHARMACOLOGY AND DISTRIBUTION OF HUMAN 5-HYDROXYTRYPTAMINE(2B) (5-HT2B) RECEPTOR GENE-PRODUCTS - COMPARISON WITH 5-HT2A AND 5-HT2C RECEPTORS
    BONHAUS, DW
    BACH, C
    DESOUZA, A
    SALAZAR, FHR
    MATSUOKA, BD
    ZUPPAN, P
    CHAN, HW
    EGLEN, RM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (04) : 622 - 628
  • [6] PHARMACOKINETICS OF FENFLURAMINE AND NORFENFLURAMINE IN VOLUNTEERS GIVEN D-FENFLURAMINE AND DL-FENFLURAMINE FOR 15 DAYS
    CACCIA, S
    CONFORTI, I
    DUCHIER, J
    GARATTINI, S
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (02) : 221 - 224
  • [7] Proinflammatory Phenotype of Perivascular Adipocytes Influence of High-Fat Feeding
    Chatterjee, Tapan K.
    Stoll, Lynn L.
    Denning, Gerene M.
    Harrelson, Allan
    Blomkalns, Andra L.
    Idelman, Gila
    Rothenberg, Florence G.
    Neltner, Bonnie
    Romig-Martin, Sara A.
    Dickson, Eric W.
    Rudich, Steven
    Weintraub, Neal L.
    [J]. CIRCULATION RESEARCH, 2009, 104 (04) : 541 - U237
  • [8] COHEN ML, 1981, J PHARMACOL EXP THER, V218, P421
  • [9] Fernández-Alfonso MS, 2010, ADVANCES IN VASCULAR MEDICINE, P175, DOI 10.1007/978-1-84882-637-3_10
  • [10] GARATTINI S, 1975, POSTGRAD MED J, V51, P27